Montelukast Sandoz

Montelukast, the active ingredient in Montelukast Sandoz, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is employed to manage chronic asthma and allergic rhinitis, reducing airway inflammation and nasal symptoms in adults and children as directed by a healthcare professional.

GNH USA supplies Montelukast Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential respiratory medication.

Montelukast Sandoz is a leukotriene receptor antagonist used in the management of respiratory and allergic conditions.

Asthma (maintenance therapy): improves long‑term control by decreasing bronchial hyper‑responsiveness and reducing the frequency of asthma exacerbations. Allergic rhinitis: alleviates nasal congestion, sneezing and itching by blocking leukotriene‑mediated inflammation in the nasal passages. Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity in susceptible individuals, supporting better exercise tolerance.

Montelukast may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate head pain. - Abdominal pain: discomfort in the stomach region. - Cough: occasional dry cough. - Dyspepsia: indigestion or upset stomach.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Angioedema: rapid swelling of face, lips, tongue or throat. - Hepatic injury: signs of liver dysfunction such as jaundice or elevated enzymes.

When prescribing Montelukast Sandoz, clinicians should consider several precautionary measures to ensure safe use.

- Assess liver function: evaluate baseline hepatic enzymes, especially in patients with liver disease. - Monitor for neuropsychiatric events: watch for mood changes, depression or suicidal thoughts. - Use caution in patients with severe asthma: ensure it is part of a comprehensive asthma plan, not a rescue medication. - Review concomitant medications: consider potential interactions that may alter drug exposure. - Store below 25°C: keep in the original pack, protect from moisture.

Montelukast can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Ritonavir: may increase montelukast plasma concentrations, raising risk of adverse effects. - Phenobarbital: may markedly reduce montelukast levels, compromising efficacy. - Ketoconazole: can elevate montelukast exposure, potentially leading to toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: montelukast may enhance anticoagulant effect, requiring INR monitoring. - Theophylline: concurrent use may increase theophylline levels, necessitating dose adjustment. - Beta‑agonists: additive bronchodilatory effect may occur, monitor respiratory status.